Key Highlights
- Vertex Pharmaceuticals’ $10 billion cash acquisition of Crinetics Pharmaceuticals sent shares soaring 100%
- Rivian’s stock plunged 9% following announcement of 75 million share offering to repay federal loan
- Micron shares declined 5% amid concerns over potential memory chip oversupply from competitors
- Fiserv rallied as much as 8% on news of potential STAR Network sale to banking giants
- Semiconductor and AI stocks experienced broad declines, with Intel losing 4.4% and Samsung falling nearly 7%
Semiconductor and artificial intelligence stocks experienced significant pressure during Tuesday’s premarket session on July 7, signaling an abrupt conclusion to the previous day’s recovery.
The downturn began overseas with Samsung Electronics. Despite projecting substantial profit growth, the Korean semiconductor giant saw investors flee, pushing shares down almost 7%.
The bearish sentiment quickly migrated to American exchanges. Intel shed 4.4% while Micron Technology tumbled 5.8% ahead of market open.
Additional technology names including Advanced Micro Devices, Corning, Marvell Technology, and Super Micro Computer also traded lower. Each company maintains significant exposure to artificial intelligence markets.
Nasdaq futures declined while Dow futures demonstrated greater resilience. Market participants seemed to be reassessing artificial intelligence sector valuations before key economic releases scheduled later in the week.
Vertex’s $10 Billion Crinetics Acquisition Sends Shares Soaring
Crinetics Pharmaceuticals emerged as the session’s most impressive performer. The stock skyrocketed 100%, climbing to $83.66 during premarket hours.
Vertex Pharmaceuticals announced plans to acquire Crinetics at $85 per share through an all-cash transaction. The agreement values total equity at approximately $10 billion.
Completion of the transaction is anticipated during the third quarter of 2026. Vertex indicated the purchase would generate immediate revenue through Palsonify’s commercialization, a therapy targeting acromegaly patients.
Vertex highlighted pipeline candidate atumelnant as having multi-billion-dollar revenue potential. The combined product portfolio is projected to deliver over $5 billion in peak yearly sales.
Fiserv shares also climbed, advancing between 6% and 8%. According to Wall Street Journal reporting, JPMorgan Chase, Bank of America, Wells Fargo, and PNC Financial Services engaged in discussions to acquire Fiserv’s STAR Network payment processing division.
Rivian Slides on Equity Offering, Micron Pressured by Oversupply Concerns
Rivian Automotive ranked among the session’s worst performers. The stock dropped approximately 9% after revealing plans to issue 75 million Class A common shares.
Rivian intends to use offering proceeds for general corporate needs, including retiring a $4.5 billion loan facility from the U.S. Department of Energy.
The electric vehicle manufacturer did deliver second-quarter revenue projections exceeding expectations. Rivian forecast revenue between $1.55 billion and $1.65 billion, surpassing the $1.44 billion Wall Street consensus estimate.
Micron declined roughly 5%. Market concerns centered on heavy capital expenditures by Samsung and SK Hynix potentially creating memory chip oversupply conditions and depressing pricing.
SpaceX edged down 1.3% in premarket activity. The aerospace company was scheduled to join the Nasdaq 100 index before Tuesday’s opening bell.
Stock index futures presented a mixed picture overall. Trading patterns reflected investors balancing positive biotechnology merger news against headwinds facing semiconductor and electric vehicle sectors.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
